Overview
CD3 operates as an investment fund and drug discovery center focusing on discovering new drugs based on innovative science from partner institutions. The organization bridges the gap between biomedical research from academic institutes and biotechs with the pharmaceutical industry, offering state-of-the-art drug discovery expertise and capabilities while investing in drug discovery spin-offs and biotechs.
In the news
- Promising Dengue Antiviral. Clinical evidence in humans. And now, a new opportunity to take mosnodenvir forward. #Mosnodenvir, is a broad spectrum #Dengue antiviral which demonstrated antiviral activity in humans. New clinical findings reported by Professor Anna Durbin from the Department of International Health, Johns Hopkins Bloomberg School of Public Health in NEJM further strengthen the clinical evidence, confirming the dose-dependent antiviral activity of daily dosing and extending these findings to once-weekly administration.
- Your science deserves the opportunity to become tomorrow’s medicines. That is what drives us at CD3. Working alongside academic partners, spin-off companies and biotech innovators, we combine drug discovery expertise and investment to advance breakthrough science into innovative medicines. Over the years, we have established more than 20 partnerships with pharma and biotech companies, helping transform scientific potential into opportunities for further development and new company creation. Our NEW website showcases what CD3 stands
- This week, the CD3 team stepped away from the lab and office for our annual team-building day. A chance to connect, share ideas and enjoy some time together outside our daily work. Bringing together different backgrounds and expertise is central to how we work at CD3. And building strong connections within our team is just as important as the partnerships we build with researchers and biotech innovators. A big thank you to everyone who made it such a great day!
- We are looking for a Lead Biologist to join us in Leuven, Belgium. If you are passionate about discovery science and want to be part of a team of early drug discovery enthusiasts, we’d love to hear from you! Apply by sending your resume by September 18th to jobs@cd3.be.
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.